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Normal dynamics between microbiota and dendritic
cells (DCs) support modest numbers of T cells, yet
these do not cause inflammation. The DCs that
induce inflammatory T cells and the signals that drive
this process remain unclear. Here, we demonstrate
that small intestine DCs lacking the signaling attenu-
ator A20 induce inflammatory T cells and that the
signals perceived and antigen-presenting cell (APC)
functions are unique for different DC subsets. Thus,
although CD103+CD11b DCs exclusively instruct
IFNg+ T cells, CD103+CD11b+ DCs exclusively
instruct IL-17+ T cells. Surprisingly, APC functions
of both DC subsets are upregulated in aMyD88-inde-
pendent fashion. In contrast, CD103CD11b+ DCs
instruct both IFNg+ and IL-17+ T cells, and only
the IL-17-inducing APC functions require MyD88. In
disease pathogenesis, both CD103CD11b+ and
CD103+CD11b+ DCs expand pathologic Th17 cells.
Thus, in disease pathogenesis, specific DCs instruct
specific inflammatory T cells.
INTRODUCTION
The mucosal immune system must co-exist with a large and
diverse number of intestine-resident microorganisms, collec-
tively referred to as the intestinal microbiota. It is now clear
that intestinal microbiota can potently influence the composition
and function of immune cells, including mucosal T cells (Honda
and Littman, 2012). Although microbiota-reactive T cells natu-
rally exist during health, an increase in abundance, stimulation,
or function of these T cells is thought to contribute to the devel-
opment of inflammatory bowel disease (IBD).
Dendritic cells (DCs) are specialized antigen-presenting cells
(APCs) that sense microbes, activate naive T cells, and regulate
immunity (Steinman, 2012; Hammer and Ma, 2013). DCs of1330 Cell Reports 17, 1330–1343, October 25, 2016 ª 2016 The Auth
This is an open access article under the CC BY-NC-ND license (http://intestine lamina propria (LP) were thought to uniformly express
CD103; however, with recent lineage verification of a CD103–
DC population (Cerovic et al., 2013; Scott et al., 2015), three
bona fide DC subsets are now recognized: CD103+CD11b,
CD103+CD11b+ and CD103–CD11b+ DCs. All three express
Zbtb46, require FLT3 ligand, and migrate to lymph nodes (Bogu-
novic et al., 2009; Varol et al., 2009; Cerovic et al., 2013; Scott
et al., 2015). In lymph nodes, and possibly within intestine,
DCs instruct T cell responses (Geem et al., 2014; Goto et al.,
2014; Semmrich et al., 2012; Bekiaris et al., 2014). Normal dy-
namics between microbiota and DCs support modest numbers
of interferon g (IFNg)-producing, T helper 1 (Th1), and interleukin
17 (IL-17)-producing (Th17) CD4 T cells, although these do not
cause inflammation. The DC subsets and APC functions that
give rise to inflammatory T cells, particularly those that cause
IBD, remain poorly understood.
APC functions of DCs are upregulated by inflammatory signals
and MyD88 signals, which include signals from Toll-like receptor
(TLR), and IL-1R and IL-18R signals pathways are considered to
be the most potent (Hou et al., 2008; Spo¨rri and Reis e Sousa,
2005; Iwasaki and Medzhitov, 2010). MyD88 signals are trig-
gered bymicrobiota, and in certain settings, MyD88 signals drive
inflammation in the colon (Hoshi et al., 2012; Feng et al., 2010).
Exactly howMyD88 signals triggered by microbiota drive inflam-
mation or control DC functions is unclear. One difficulty is that in
health, intestinal DCs and their migratory counterparts in lymph
nodes have limited APC function (Persson et al., 2013; Fujimoto
et al., 2011). Exogenous inflammatory stimuli are required to
enhance APC functions, and these may alter DCs in non-physi-
ologic ways. The physiologic signals that control APC functions
are a topic of great interest, because these signals likely control
how DCs instruct T cells, and each of the three DC subsets of in-
testinemay instruct different T cells, particularly Th17 cells (Pers-
son et al., 2013; Schlitzer et al., 2013; Bekiaris et al., 2014).
We previously reported DCs lacking A20 (gene name Tnfaip3),
an intracellular suppressor of multiple signaling pathways (Lee
et al., 2000; Boone et al., 2004; Hitotsumatsu et al., 2008), are hy-
per-responsive to physiologic MyD88 signals and physiologic
signals that are MyD88 independent (Hammer et al., 2011).or(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
Although both signals enhanced DC stimulation of T cells in
mice with DC-specific, Cd11c-cre, conditional knockout of A20
(A20cko mice), DC expansion of T cells in lymph nodes occurred
in an exclusively MyD88-dependent fashion (Hammer et al.,
2011). While the pathologic potential of MyD88 is known, the
physiologic settings wherein MyD88-independent signals have
a potent effect on DCs and whether such signals can be patho-
logic are unknown. In IBD, human genetic studies link A20 to
Crohn’s disease and ulcerative colitis (Wellcome Trust Case
Control Consortium et al., 2007; Graham et al., 2008; 1000 Ge-
nomes Project Consortium et al., 2012), and in IBD, DC-intrinsic
signaling pathways (MyD88 dependent and perhaps MyD88 in-
dependent) could be pathologic.
Here, we used A20cko mice to determine how intestinal DCs
regulate T cells and intestinal homeostasis. We also used
mice with DC-specific loss of both A20 and MyD88 (A20/
Myd88cko mice) to determine the roles of physiologic MyD88
signals. We show that A20cko mice develop inflammation of
the small intestine that requires microbiota, DCs, and T cells.
Surprisingly, DC expansion of inflammatory T cells can occur
in a MyD88-independent fashion. Without the need for exoge-
nous stimuli, all three intestinal DC subsets in A20cko mice
have remarkable ability to activate naive T cells and instruct
cytokine production. We further show that in the small intestine,
CD103CD11b+ and CD103+CD11b+ DCs instruct and expand
pathologic Th17 cells, indicating that in disease pathogenesis,
specific DC subsets instruct specific types of inflammatory
T cells.
RESULTS
DCs Drive Spontaneous Inflammation in the Small
Intestine in a MyD88-Independent Fashion
Inflammatory bowel disease involves dynamics between
microbe and host, and we previously reported that A20cko
mice develop inflammation in the colon (Hammer et al., 2011).
Colon anatomy, physiology, and cellular composition are distinct
from those of the small intestine, and inflammation does not
affect both organs by default. We thus tested whether DC
expression of A20 was required for small intestine homeostasis.
Remarkably, the small intestine of A20cko mice was inflamed,
which resulted in increased organ weight and thickening of the
intestinal wall (Figures 1A and S1A). Small intestine inflammation
occurred by 10 weeks of age and preceded colitis (Figure S1A),
which is most prominent in mice 6 months or older (Hammer
et al., 2011). Inflammation did not occur in co-housed, littermate
control, A20wt mice (see Experimental Procedures for co-hous-
ing). Given the disease severity, we hypothesized that MyD88,
which is known to drive lymphadenopathy in A20cko mice
(Hammer et al., 2011), was required for small intestine inflamma-
tion. In contrast to our predictions, A20/Myd88cko mice also
demonstrated severe small intestine inflammation and increased
organ weight (Figures 1A and S1A). Genomic qPCR confirmed
>95%deletion of A20 andMyD88 genes in DCs of small intestine
lamina propria (SI-LP) (Figure S1B). These genes were deleted to
a lesser extent in SI-LP macrophages, a fraction of which are
known to undergo gene recombination in Cd11c-cre mice (Fig-
ure S1B). Inflammation in A20/Myd88cko mice was due to lossof A20 and not loss of MyD88, since co-housed A20 wild-type
mice (Myd88cko) had no inflammation (Figure 1A).
Histologic examination showed that the small intestine organ
weight of A20cko mice and A20/Myd88cko mice was increased
due to inflammation and cellular infiltration, the extent and
severity of which were similar in both genotypes (Figure 1B).
Inflammation was generally present in all segments of the small
intestine examined but of greater extent (involving >60% of the
area) in segments containing the duodenum/proximal jejunum
and terminal ileum (Figure 1C). Inflammatory infiltrates in the
proximal jejunum (Figures 1D–1F) and terminal ileum (Figures
1G–1I) typically expanded the LP, particularly beneath crypts.
Foci of inflammatory infiltrates commonly extended into the sub-
mucosa or were transmural (Figures 1E, 1F, 1H, and 1I). Inflam-
matory infiltrate was primarily composed of mononuclear cells,
admixed with varying numbers of neutrophils. Foci of epithelioid
macrophages (granulomas) were frequent and often accompa-
nied by multinucleated giant cells (Figures 1J and 1K). Crypt ab-
scesses were also observed, particularly in the proximal jejunum
(Figure 1J). Thus, both A20cko and A20/Myd88cko mice develop
spontaneous small intestine inflammation sharing histologic fea-
tures with Crohn’s disease. In these analyses, we found little
to no pathologic inflammation in the colon despite extensive
inflammation involving the small intestine, suggesting that the
physiologic factors driving pathogenesis are unique in these
two organs. The persistence of small intestine inflammation in
A20/Myd88cko mice further suggests that physiologic signals
other than MyD88 can drive pathologic inflammation of the small
intestine.
DCs and T Cells Together Drive Small Intestine
Inflammation in a MyD88-Independent Fashion
Different DC subsets have distinct developmental requirements
and cellular responses to microbial products. To determine the
role of A20 in each DC subset of SI-LP, we analyzed the three
DC subsets using a panel of markers verified to distinguish
CD14+ macrophages from CD24+ DCs (Tamoutounour et al.,
2012; Scott et al., 2015). Using this standard approach, we
could unambiguously distinguish SI-LP macrophages and
DCs, despite inflammation in A20cko and A20/Myd88cko mice
(Figures 2A and S1C).
In control A20wt mice, A20mRNAwas abundant in SI-LPmac-
rophages, CD103+CD11b+ DCs, and CD103CD11b+ DCs (Fig-
ure 2B). CD103+CD11b DCs expressed little A20 mRNA,
although upon deletion of A20 in A20cko mice, CD80 expression
was increased 3-fold, suggesting that a low level of A20 expres-
sion was physiologically relevant. CD80 was also upregulated by
the other DCs and by macrophages (Figure 2C). While all SI-LP
DCs in A20cko mice upregulated CD80 and all failed to express
A20mRNA (Figure S1D), other maturation markers were upregu-
lated differently by each subset. Only CD103CD11b+ DCs high-
ly upregulated CD86, whereas CD40, a classical maturation
marker, was most dramatically upregulated by CD103+CD11b
DCs (Figures 2D and 2E). Neither CD86 nor CD40 was up-
regulated by CD103+CD11b+ DCs or macrophages. In bone-
marrow-derived DCs, which receive no maturation stimulus,
loss of A20 did not cause spontaneous expression of maturation
markers (Figure S1E). These data suggest that although all SI-LPCell Reports 17, 1330–1343, October 25, 2016 1331
Figure 1. A20cko and A20/Myd88cko Mice
Develop Spontaneous Small Intestine
Inflammation that Shows Histologic Fea-
tures Resembling Crohn’s Disease
(A) Organ weights of the small intestine from A20wt,
A20cko, A20/Myd88cko, and Myd88cko mice (n =
19–34 mice of each genotype, aged 9–12 weeks).
(B and C) Five segments of the small intestine (SI)
were dissected from mice of the indicated geno-
type (aged 14–20 weeks) and evaluated for pa-
thology in a blinded fashion. Segments of SI were
from proximal and middle (mid) regions and also
terminal ileum, as described in Experimental Pro-
cedures. Abbreviations: Duo, duodenum; Jej,
jejunum; Ile, ileum. The combined score of all SI
regions evaluated (B), and the individual score of
each evaluated region is shown (C).
(D–K) H&E-stained SI segments of proximal
jejunum (D–F) and the terminal ileum (G–I) are
shown at the same magnification for co-housed
14-week-old A20wt (D and G), A20cko (E and H),
and A20/Myd88cko (F and I) mice. Inflammatory
infiltrates are evident in the LP of A20cko and A20/
Myd88cko mice, particularly beneath the crypts.
These extend focally into the submucosa. (J) Ex-
amples of multinucleated giant cells characteristic
of granulomatous inflammation (black arrows) and
crypt abscesses (black arrowhead) in the prox-
imal jejunum of a 10-week-old A20cko mouse. (K)
Example of a cluster of epithelioid macrophages
(granuloma) with neutrophils (white open arrows) in
the LP and submucosa of the terminal ileum of a
14-week-old A20/Myd88cko mouse.
Thick black bar represents 100 mm. Error bars
represent mean ± SEM. *p < 0.05, ***p < 0.001,
****p < 0.0001 (unpaired Student’s t test).
See also Figure S1.DCs normally express A20, each has subset-specific character-
istics that result in distinct maturation phenotypes in A20cko
mice. Similar phenotypic changes occurred in A20/Myd88cko
mice, indicating that MyD88 was not required (Figures 2C–2E).
Despite these phenotypic changes, neither DCs or macro-
phages were numerically expanded (Figure 2F). By contrast,
Th1, Th17, and IL-17+IFNg+ CD4 T cells were expanded more
than 10-fold in A20cko mice (Figure 2G). Foxp3+ T cells were
also expanded, suggesting that expansion of CD4 T cells was
not due to deficiency in numbers of regulatory T cells (Figure 2G).
Consistent with our observation that inflammation of the small in-
testine was driven in a MyD88-independent fashion, CD4 T cells1332 Cell Reports 17, 1330–1343, October 25, 2016were also expanded more than 10-fold in
A20/Myd88cko mice (Figure 2G). These
data suggest that in the small intestine,
physiologic signals that are MyD88-inde-
pendent can induce DC maturation and
T cell expansion.
Given that SI-LP T cells were expanded
we considered that T cells may be
required for inflammation. To test this,
we crossed A20cko and A20/Myd88cko
mice with Rag1/ mice. In contrast to
Rag1-sufficient mice, small intestine organ weight of Rag1/
A20cko and Rag1/ A20/Myd88cko mice was normal and there
was no inflammation (Figures 2H, S2A, and S2B). From these
data, we conclude that SI-LP DCs in A20cko and A20/Myd88cko
mice expand pathologic T cells that cause small intestine inflam-
mation. Although T cells caused inflammation, they were not
required for DCmaturation, suggesting that this was not second-
ary to inflammation (Figures S2C and S2D). Collectively, the
persistence of DC maturation and expansion of pathologic
T cells in A20/Myd88cko mice suggests that in the small intestine,
MyD88-independent signals can potently induce pathological,
T cell-mediated inflammation.
Figure 2. In A20cko and A20/Myd88cko Mice,
Intestinal DCs Are Phenotypically Mature
and Expand Pathological Mucosal T Cells
that Cause Small Intestine Inflammation
(A) Representative flow cytometry gating strategy
in A20wt mice to identify the three bona fide DC
populations of SI-LP.
(B) Expression of A20mRNA by the indicated SI-LP
DC subset or macrophages from wild-type mice,
relative to Hprt.
(C–F) Cell-surface expression of maturation
markers CD80 (C), CD86 (D), CD40 (E) and total cell
number (F) of SI-LP DCs and macrophages.
Cellular expression of maturation markers is rep-
resented as mean fluorescence intensity (MFI)
relative to that of the same population in wild-type
(WT) mice.
(G) Cell number of SI-LP CD4+ T cells, IFNg+, IL-
17+, IFNg+IL-17+, and Foxp3+CD4+ T cells from
mice of the indicated genotype. Data in (C)–(G)
were combined from at least three independent
experiments with mice between 10 and 14 weeks
of age, including at least one mouse of each ge-
notype per experiment. Each dot represents one
mouse.
(H) Organ weights of small intestine from Rag1/
mice of the indicated genotypes (n = 9–11 mice of
each genotype, aged 12–14 weeks). Error bars
represent mean ± SEM. *p < 0.05, **p < 0.01,
****p < 0.0001 (unpaired Student’s t test).
See also Figure S2.Microbiota Trigger MyD88-Independent Pathways to
Induce Small Intestine Inflammation
Although microbiota are well known to trigger MyD88 signals
that expand pathologic T cells, these observations were made
in the colon (Hoshi et al., 2012; Feng et al., 2010). We hypothe-
sized that microbiota can also trigger MyD88-independent
signals to induce pathologic T cells in the small intestine. To
test this in A20cko and A20/Myd88cko mice, we added antibiotics
to the drinking water of lactating dams and their offspring
until 10 weeks of age. Antibiotics decreased stool 16S DNA
by a minimum factor of 104 (Figure S3A). Separate cohorts ofCell Repoage-matched mice provided water alone
were analyzed together with antibiotic-
treated mice as untreated, genotype-
matched controls. In contrast to mice
provided water alone, organ weight of
the small intestine in antibiotic-treated
A20cko and A20/Myd88cko mice was
similar to that of antibiotic-treated A20wt
mice (Figure 3A). Moreover, antibiotics
prevented inflammation (Figures S3B
and S3C). These data indicate that small
intestine inflammation in A20cko and
A20/Myd88cko mice required microbiota.
Microbiota-reactive T cells exist in
health but do not cause inflammation
(Honda and Littman, 2012). Thus, antibi-
otics given to A20wt mice reduced Th17cells 8-fold (Figure 3B). Th17 cells, which expanded and were
pathologic in A20cko mice, were reduced 5-fold by antibiotics,
indicating that microbiota were required. Importantly, antibiotics
also reduced Th17 cells in A20/Myd88cko mice, a 7-fold
decrease compared to A20/Myd88cko mice given water alone
(Figure 3B). Collectively, these data indicate that expansion of
pathologic Th17 cells and small intestine inflammation in
A20cko and A20/Myd88cko mice were both driven in a micro-
biota-dependent fashion. Additionally, in the small intestine, mi-
crobiota-triggered signals that are independent of MyD88 can
potently induce inflammatory Th17 cells.rts 17, 1330–1343, October 25, 2016 1333
Figure 3. Microbiota Are Required for Small
Intestinal Inflammation and Expansion of
Pathological Mucosal T Cells in A20cko and
A20/Myd88cko Mice
(A) Organ weights of small intestine from mice of
the indicated genotypes, treated with or without
broad-spectrum antibiotics (Abx) for 9–10 weeks.
Organ weight is relative to the average of A20wt
mice, within each treatment group.
(B–D) Mice from each treatment group was
analyzed for cell number of SI-LP IL-17+ (B), IFNg+
(C), and IFNg+IL-17+ CD4 T cells (D). Each dot
represents one mouse. Results are combined from
four independent experiments.
Error bars show mean ± SEM, *, p < 0.05; **, p <
0.01; ***, p < 0.001, ****, p < 0.0001 (unpaired
Student’s t test). See also Figure S3.Th1 cells are also present in the healthy intestine, although mi-
crobiota-reactive Th1 cells are poorly defined. Although A20cko
and A20/Myd88cko mice had abundant Th1 cells, antibiotics
did not reduce these, although there was a downward trend in
A20/Myd88cko mice (Figure 3C). Unlike Th1, antibiotics reduced
IFNg+IL-17+ T cells in A20cko and A20/Myd88cko mice 5-fold (Fig-
ure 3D), suggesting that these IFNg-producing T cells were
expanded in a microbiota-dependent fashion and were linked
to small intestine inflammation in A20cko and A20/Myd88cko
mice. Collectively, these data support a pathologic role for sig-
nals independent of MyD88 in dynamics among microbiota,
DCs, and T cells in the small intestine.
CD103+CD11b DCs and CD103+CD11b+ DCs Have
Biased APC Functions that Are Upregulated in a
MyD88-Independent Fashion
In the absence of an exogenous stimulus, SI-LP DCs from WT
mice have a limited ability to instruct naive T cells to produce
IFNg or IL-17 (Fujimoto et al., 2011; Persson et al., 2013).
Because these T cell populations expanded and caused small
intestine inflammation in A20cko mice, we hypothesized that
SI-LP DCs in these mice have enhanced and pathologic APC
functions. Additionally, because T cells expanded similarly in
A20cko and A20/Myd88cko mice, we reasoned that physiologic
signals independent of MyD88 were sufficient to induce patho-
logic DC functions in one or more DC subsets. To test these hy-
potheses, we sorted each DC subset and assayed APC function
in co-cultures with naive OT-II T cells plus endotoxin-free Ova
peptide. Importantly, no exogenous stimuli were added.
We first analyzed CD103+CD11b DCs. When isolated from
A20wt mice, CD103+CD11b DCs instructed less than 0.3% of
all T cells to produce either IFNg or IL-17 (Figure 4A). In stark
contrast, CD103+CD11b DCs from A20cko mice induced a
robust population of IFNg+ T cells (more than 250-fold that
of wild-type) (Figures 4A and 4B). CD103+CD11b DCs from1334 Cell Reports 17, 1330–1343, October 25, 2016A20/Myd88cko mice had a similarly robust
ability to instruct IFNg+ T cells, indicating
that MyD88 signals were not required to
enhance APC function (Figures 4A and
4B). Interestingly, although IFNg-inducingAPC functions were markedly enhanced in CD103+CD11b
DCs from A20cko and A20/Myd88cko mice, these same DCs had
little ability to induce IL-17+ T cells (Figures 4A and 4B). Thus,
although CD103+CD11b DCs from A20cko and A20/Myd88cko
mice could instruct as many as 40% of all T cells to produce
IFNg, populations of IL-17+ T cells were consistently less than
0.3%. The strong bias of CD103+CD11b DCs toward IFNg-
inducing APC functions was further supported by ELISA of cyto-
kine in DC/T cell co-culture supernatant. While IFNg protein in
CD103+CD11b co-cultures from A20cko and A20/Myd88cko
mice was increased more than 100-fold compared to control,
IL-17 protein remained low and was statistically similar to A20wt
co-cultures (Figure 4C). These data suggest that CD103+CD11b
DCs are strongly biased to instruct inflammatory Th1 cells.
In mirror image, CD103+CD11b+ DCs isolated from A20cko
mice preferentially instructed IL-17+ T cells (Figures 4D and
4E). Compared to A20wt, IL-17-inducing APC functions of
CD103+CD11b+ DCs from A20cko mice were enhanced more
than 5-fold and remained elevated in CD103+CD11b+ DCs
from A20/Myd88cko mice (Figures 4D and 4E). By contrast, in
these same co-cultures, we detected very few IFNg+ T cells.
Enhanced and biased instruction of IL-17+ T cells was also re-
flected in supernatants of CD103+CD11b+ DC co-cultures from
A20cko and A20/Myd88cko mice. In these co-cultures, the abun-
dance of IL-17 protein was increased more than 300-fold
compared to controls (Figure 4F). IFNg protein was modestly
increased and may have been produced by IFNg+IL-17+
T cells, since these were induced at much higher frequencies
in both A20cko and A20/Myd88cko CD103+CD11b+ DC co-cul-
tures (Figure S4A). These data suggest that CD103+CD11b+
DCs are heavily biased to instruct inflammatory Th17 cells.
In DC/T cell co-cultures, we found a correlation between
increased percentages of IFNg+ or IL-17+ T cells and a reduced
percentage of Foxp3+ T cells (Figure S4B). We also tested APC
functions of SI-LP macrophages from A20cko and A20/Myd88cko
Figure 4. Each SI-LP DC Subset Possesses Unique APC Functions and Differential Requirements for MyD88 Signals
SI-LP CD103+CD11b DCs were isolated from mice of the indicated genotype and co-cultured 1:1 with naive OT-II T cells for 4 days.
(A) Representative flow plots of IFNg+ and IL-17+ T cells in each CD103+CD11b DC/T cell co-culture.
(B and C) The percentages of IFNg+ or IL-17+ CD4 T cells (B) and ELISA quantification of IFNg and IL-17 protein (C) in co-cultures of CD103+CD11b DCs from
A20wt, A20cko, and A20/Myd88cko mice.
(D–I) OT-II co-cultures with CD103+CD11b+ DCs (D–F) or CD103CD11b+ DCs (G–I) were assayed as above. Data are combined from three independent ex-
periments. Each dot represents one experiment, or replicates within an experiment, using DCs pooled from at least three mice of each genotype and including all
three genotypes for each experiment.
(J–L) CD103CD11b+ DCs isolated from co-housed Myd88wt and Myd88cko mice were co-cultured with naive OT-II T cells, as above. The percentages (J) and
total cell number (K) of IFNg+ or IL-17+ T cells, or IFNg or IL-17A protein in culture supernatant (L) assayed from two independent experiments, with at least five
mice per genotype and including both genotypes for each experiment. Each dot represents replicates within an experiment.
Error bars represent mean ± SEM, *, p < 0.05, **, p < 0.01, ****, p < 0.0001, (unpaired Student’s t test). See also Figure S4.mice and found few IFNg+ or IL-17+ T cells (<1,000-fold that of
DCs from the same mice) (Figure S4C). Less than one IFNg+ or
IL-17+ T cell was generated by each macrophage, and the total
number of T cells remaining in macrophage co-cultures was
significantly less than that found in DC co-cultures. These data
suggest that SI-LP macrophages in A20cko and A20/Myd88ckomice have little ability to instruct naive CD4 T cells to produce
cytokines and that these APC functions were most potently
upregulated by DCs. Alternatively, although most SI-LP macro-
phages recombined the floxed A20 allele and as a bulk popu-
lation some cytokine genes were upregulated (Figures S1B
and S4D), it is possible that the remaining A20-sufficientCell Reports 17, 1330–1343, October 25, 2016 1335
macrophages suppress naive T cell activation, as previously
described (Denning et al., 2007). Nevertheless, in contrast to
macrophages, it is clear that SI-LP CD103+CD11b and
CD103+CD11b+ DCs from A20cko and A20/Myd88cko mice DCs
can potently activate naive T cells and instruct inflammatory
cytokine production, with surprisingly biased instruction for
IFNg or IL-17. It appears that the physiologic signals that can up-
regulate APC functions of CD103+CD11b+ and CD103+CD11b
DCs are independent of MyD88.
IL-17-Inducing APC Functions of CD103CD11b+ DCs
Require MyD88
CD103CD11b+ DCs are the least abundant SI-LP DC subset,
and little information exists on this population (Scott et al.,
2015; Cerovic et al., 2013). When we tested APC functions of
CD103CD11b+ DCs fromwild-typemice, we routinely detected
2% or more cytokine-producing T cells, which was a much
higher percentage compared to CD103+ DC co-cultures (Figures
4G and 4H). Wild-type CD103CD11b+ DCs instructed IFNg+ or
IL-17+ T cells with equal efficiency and were the most capable
DC subset for instruction of IL-17+IFNg+ T cells (Figure S4A).
Our findings confirm that in health, CD103CD11b+ DCs
possess dual APC functions (Scott et al., 2015). Interestingly,
both IFNg- and IL-17-inducing APC functions were enhanced
in CD103CD11b+ DCs from A20cko mice (Figures 4G and 4H).
Thus, loss of A20 did not appear to introduce bias to APC func-
tions but instead upregulated the dual IFNg- and IL-17-inducing
APC functions that were readily apparent in A20wt DCs.Whenwe
tested whether APC functions of CD103CD11b+ DCs required
MyD88, we were surprised to find that MyD88 was selectively
required to induce IL-17+ T cells (Figures 4G and 4H). Thus, while
CD103CD11b+ DC co-cultures from A20cko and A20/Myd88cko
mice had similar percentages of IFNg+ T cells and IFNg protein,
IL-17+ T cells and IL-17 protein were reduced 3-fold in A20/
Myd88cko DC co-cultures (Figures 4G–4I). Collectively, these
data suggest that while IFNg-inducing APC functions were upre-
gulated in a MyD88-independent fashion in CD103CD11b+
DCs, instruction of IL-17+ T cells required MyD88.
Given these results, we reasoned that MyD88 should also play
a role in APC functions of A20wt, CD103CD11b+ DCs. We
tested this by performing a side-by-side analysis of SI-LP DCs
from A20wt/Myd88wt (Myd88wt) and littermate A20wt/Myd88cko
mice (Myd88cko). CD103CD11b+ DCs from Myd88wt and
Myd88cko mice were equal in terms of expansion of IFNg+
T cells, and co-cultures contained similar amounts of IFNg pro-
tein (Figures 4J–4L). However, in the absence of MyD88, IL-
17+ T cells were reduced 5-fold. Loss of APC functions due to
MyD88 deficiency was specific to CD103CD11b+ DCs, since
we found no differences in APC functions of CD103+ DCs from
Myd88wt or Myd88cko mice (Figures S4E–S4G). These data sug-
gest that among SI-LP DCs, physiologic MyD88 signals have the
most potent influence on APC functions of CD103CD11b+ DCs,
and in these DCs, MyD88 selectively upregulates IL-17-inducing
APC functions. Because CD103CD11b+ DCs from A20wt and
A20cko mice both upregulate IL-17-inducing APC functions in a
MyD88-dependent fashion, the link between MyD88 and
CD103–CD11b+ DC-instruction of IL-17+ T cells appears to be
required in health and in inflammation.1336 Cell Reports 17, 1330–1343, October 25, 2016Distinct Mechanisms Enhance IFNg- or IL-17-Inducing
APC Functions of SI-LP DCs
Our results above suggested that APC functions of SI-LP DCs
were enhanced in A20cko mice and that each DC subset
possessed unique, subset-specific APC functions. In intestinal
DCs, it is not known what mechanisms enhance DC instruction
of T cells or whether APC functions of IFNg-inducing and IL-
17-inducing DCs can be enhanced by a common mechanism.
To test if the different DC subsets use similar or distinct mecha-
nisms to instruct IFNg+ or IL-17+ T cells, we added blocking an-
tibodies to DC/T cell co-cultures. We first tested requirements
for CD80/86 given that all three SI-LP DCs in A20cko mice upre-
gulated one or both molecules (Figure 2).
CD103+CD11b DCs from A20cko mice have enhanced and
biased abilities to instruct IFNg+ T cells (Figure 4). In co-cultures
with control antibody, numbers of IFNg+ T cells were increased
>25-fold compared to control DCs (Figure 5A). By contrast,
upon addition of CD80/86 blocking antibodies, IFNg+ T cells
were essentially abolished (Figure 5A). Numerically, CD80/86
blocking resulted in 20-fold fewer IFNg+ T cells in co-cultures
of CD103+CD11b DCs from A20cko mice. Comparatively the
total T cell number in these co-cultures was at most reduced
2.5-fold (Figure S5), suggesting that blocking CD80/86 most
significantly blocked instruction of IFNg+ T cells, APC functions
that were otherwise enhanced in CD103+CD11b DCs from
A20cko mice. From these data we conclude that enhanced
IFNg-inducing APC functions of CD103+CD11b DCs from
A20cko mice require DC expression of CD80/86 costimulatory
molecules.
IFNg-inducing APC functions were also enhanced in
CD103CD11b+ DCs from A20cko mice (Figure 4). CD80/86
blocking markedly decreased the number of IFNg+ T cells
expanded by CD103CD11b+ DCs, similar to results with
CD103+CD11b DCs (Figure 5B). Thus, upregulation of CD80/
86 by SI-LP DCs can enhance instruction of IFNg+ T cells. These
data also suggest that despite their subset-specific differences,
cellular mechanisms that enhance APC functions are shared by
CD103+CD11b and CD103CD11b+ DCs. Notably, between
these two, only CD103CD11b+ DCs possess both IFNg- and
IL-17-inducing APC functions (Figure 4). Thus, by using
CD103CD11b+ DCs, we could test whether CD80/86 expres-
sion, on the same DC, was required to instruct IFNg+ T cells
and also IL-17+ T cells. Surprisingly, while CD80/86 blocking an-
tibodies in CD103CD11b+ DC co-cultures reduced numbers of
IFNg+ T cells 9-fold, the numbers of IL-17+ T cells changed very
little (1.6-fold) (Figures 5B and 5C). These data suggest that
cellular mechanisms that enhance IL-17-inducing APC functions
of CD103CD11b+ DCs do not require CD80/86 and are thus
distinct from mechanisms that instruct IFNg+ T cells. In support
of this conclusion, CD103+CD11b+ DCs from A20cko mice, which
have enhanced and biased abilities to instruct IL-17+ T cells (Fig-
ure 4), were not inhibited by CD80/86 blocking antibodies (Fig-
ure 5D). Thus, IL-17-inducing APC functions upregulated by
CD103+CD11b+ and CD103CD11b+ DCs of A20cko mice did
not require CD80/86. Collectively, these data indicate that
physiologic signals that enhance IFNg-inducing APC functions
of SI-LP DCs do so in part by upregulating CD80/86, but this
does not enhance IL-17-inducing APC functions.
Figure 5. Enhanced APC Functions of IFNg-Inducing DCs Require CD80/86, and IL-17-Inducing DCs Require IL-6
(A and B) Number of IFNg+ T cells induced in co-cultures with SI-LP CD103+CD11b DCs (A) or CD103CD11b+ DCs (B) from A20wt and A20cko mice as in
Figure 4, in the presence of antibodies blocking CD80 and CD86 (anti-CD80/86) or isotype control (iso).
(C) Numbers of IL-17+ T cells induced in CD103CD11b+ DC co-cultures from (B) were assayed in parallel.
(D and E) Number of IL-17+ T cells induced in CD103+CD11b+ DC co-cultures in the presence of anti-CD80/86 (D) or IL-6 blocking antibody (E).
(F and G) Number of IL-17+ T cells induced in co-cultures with CD103CD11b+ DCs (F) in the presence of IL-6 blocking antibody or isotype control. (G) The
number of IFNg+ T cells induced in CD103CD11b+ DC co-cultures from (F) was assayed in parallel.
(H) Numbers of IFNg+ T cells induced in CD103+CD11bDC co-cultures in the presence of IL-6 blocking antibody or isotype control. Results were combined from
three independent experiments, each including pooled DCs from at least three mice of each genotype.
Error bars represent mean ± SEM. See also Figure S5.Several cytokines are suggested to play a role in instruction or
survival of IL-17+ T cells, including IL-6 (Denning et al., 2011;
Persson et al., 2013; Hu et al., 2011). IL-6 can also support
IFNg+ T cells, particularly in inflammation (Dejean et al., 2009;
Nish et al., 2014). To test whether IL-6 enhances IFNg-inducing
and/or IL-17-inducing functions of SI-LP DCs, we added IL-6
blocking antibodies to DC/T cell co-cultures. CD103+CD11b+
DCs from A20cko mice have enhanced and biased ability to
instruct IL-17+ T cells (Figure 4), and essentially all IL-17+
T cells were abolished upon addition of IL-6 blocking antibody
(Figure 5E). IL-6 blockade also abolished IL-17+ T cells from
co-cultures of CD103CD11b+ DCs (Figure 5F), indicating that
IL-6 was required for APC functions of both CD103+CD11b+
and CD103CD11b+ DCs. Again, because CD103CD11b+
DCs possessed dual APC functions, we tested whether IL-6 ex-
pressed by those DCs enhanced both IL-17- and IFNg-inducing
APC functions. In marked contrast to IL-17+ T cells, IL-6
blockade in CD103CD11b+ DC co-cultures did not inhibit
expansion of IFNg+ T cells (Figure 5G). Consistent with this
result, IL-6 blockade did not impair expansion of IFNg+ T cellsby CD103+CD11b DCs (Figure 5H). These data suggest that
IL-6 is selectively required to enhance IL-17-inducing APC func-
tions of SI-LP DCs.
IL-1b and tumor necrosis factor a (TNF-a) could also influence
DC instruction of T cells (Shaw et al., 2012), but blocking anti-
bodies to these cytokines did not impair APC functions of any
DC subset (data not shown). Our results suggest that among
SI-LP DCs, upregulation of IFNg-inducing APC functions corre-
late with upregulation of CD80/86, whereas IL-17-inducing
APC functions require upregulation of IL-6. These molecules
were similarly required by SI-LP DCs from A20/Myd88cko mice
(data not shown). High expression of CD80/86 and IL-6 by SI-
LP DCs of A20cko and A20/Myd88cko mice likely contributes to
T cell-mediated inflammation of the small intestine.
SI-LP DCs Have Subset-Specific Requirements for
MyD88 to Drive Cytokine Gene Expression
Our results above indicated that only specific DCs upregulated
IL-17-inducing APC functions, and these required IL-6. The
physiologic signals that induce IL-6 and whether inducibleCell Reports 17, 1330–1343, October 25, 2016 1337
expression of IL-6 is exclusive to IL-17-inducing DC subsets are
not known. To investigate these questions, we first quantified IL-
6 mRNA in CD103+CD11b DCs. Because CD103+CD11b DCs
failed to instruct IL-17+ T cells (Figure 4), we reasoned that these
DCs failed to upregulate IL-6. Surprisingly, CD103+CD11b DCs
from A20cko mice and also A20/Myd88cko mice expressed high
IL-6 mRNA (upregulated 4-fold compared to controls) (Fig-
ure 6A). These results stood out to us for two reasons. First,
because these DCs did not instruct IL-17+ T cells, these data
suggest that upregulation of IL-6 by CD103+CD11b DCs was
insufficient to upregulate IL-17-inducing APC functions. Thus,
high expression of IL-6 is not exclusive to IL-17-inducing SI-LP
DCs. Second, these data indicate that in CD103+CD11b DCs,
IL-6 can be upregulated in a MyD88-independent fashion.
We next analyzed CD103+CD11b+ DCs. These DCs from
A20cko and A20/Myd88cko mice have an enhanced ability to
instruct IL-17+ T cells (Figure 4). Because IL-17-inducing APC
functions of CD103+CD11b+ DCs do not require MyD88, we
reasoned that IL-6 mRNA would be upregulated in DCs of both
A20cko and A20/Myd88ckomice. However, while CD103+CD11b+
DCs from A20cko mice indeed expressed high levels of IL-6, DCs
from A20/Myd88cko mice did not, indicating that physiologic
MyD88 signals were required (Figure 6B). Moreover, IL-6
mRNA in CD103+CD11b+ DCs from A20/Myd88cko mice was
identical to A20wt, suggesting high IL-6 (significantly above
wild-type) is likely not the only factor that enhances IL-17-
inducing APC functions. Accordingly, IL-6 mRNA above wild-
type was seemingly not required to enhance IL-17-inducing
APC functions of CD103CD11b+ DCs, since IL-6 was similarly
expressed by CD103CD11b+ DCs from A20wt, A20cko, and
A20/Myd88cko mice (Figure 6C). We also assayed IL-6 protein
in DC/T cell co-culture supernatants and found IL-6 protein
was abundant in co-cultures of DCs from A20cko and A20/
Myd88cko mice; however, this IL-6 protein may be secondary
to T cell activation (Figure S6). Thus, when analyzed directly
ex vivo, our data suggest that IL-17-inducing APC functions of
SI-LP DCs can be enhanced without significantly increased
expression of IL-6 mRNA. Additionally, physiologic signals in
A20cko mice induce high expression of IL-6 mRNA in both
CD103+CD11b and CD103+CD11b+ DCs, and of these two,
only CD103+CD11b+ DCs upregulate IL-6 in a MyD88-depen-
dent fashion.
Given these results, we also analyzed IL-23a(p19) and IL-1b
mRNA, which are commonly induced in a MyD88-dependent
fashion, although the physiologic signals that drive expression
are unknown. Surprisingly, upregulation of IL-23a and IL-1b
mRNA was exclusive to CD103+CD11b DCs, and both
cytokines were upregulated in a MyD88-independent fashion in
this DC subset (Figures 6D–6I). IL-12a(p35) and IL-12b(p40)
mRNA were not upregulated, indicating that gene expression
was not generally ‘‘promiscuous’’ in CD103+CD11b DCs
from A20cko or A20/Myd88cko mice (Figure S7). From these
data, we conclude that physiologic signals that are independent
of MyD88 can induce IL-23a, IL-1b, and IL-6 mRNA in
CD103+CD11b DCs.
By contrast, these cytokines appeared to be induced in a
MyD88-dependent fashion in CD103+CD11b+ DCs (Figures 6B,
6E, and 6H). CD103+CD11b+ DCs from A20/Myd88cko mice1338 Cell Reports 17, 1330–1343, October 25, 2016actually expressed less IL-23a than did A20wt, suggesting that
physiologic MyD88 signals were critical (Figures 6B and 6E).
MyD88 was also required in SI-LP macrophages of A20cko
mice, which upregulated only IL-23a and IL-6 (Figure S4D).
None of the cytokine genes tested were upregulated in
CD103CD11b+ DCs (Figures 6C, 6F, 6I, and S7). Although cyto-
kine expression may be enhanced post-transcriptionally, at the
mRNA level, our findings suggest requirements for MyD88 are
unique for each cytokine and for each DC subset. Like cytokine
mRNA, each DC subset has a uniquematuration phenotype, and
together, these subset-specific factors likely enhance and bias
APC functions.
CD103+CD11b+ and CD103CD11b+ DCs Instruct
Inflammatory Th17 Cells in Disease Pathogenesis of the
Small Intestine
In health, CD103+CD11b+ DCs support Th17 cells, although
these do not cause inflammation (Persson et al., 2013; Schlitzer
et al., 2013). In pathogenesis, it is not known whether specific
inflammatory T cells require specific DC subsets. To test
whether CD103+CD11b+ DCs were required to instruct inflam-
matory Th17 cells we generated A20cko mice that lacked
CD103+CD11b+ DCs by crossing to the DC-ablation strain,
Langerin-DTA mice (Kaplan et al., 2005; Welty et al., 2013). In
Langerin-DTA mice, the human Langerin promoter drives
intracellular expression of diphtheria toxin, and this transgene
is known to ablate Langerhans cells and also SI-LP CD103+
CD11b+ DCs. We analyzed co-housed, Langerin-DTA trans-
gene-positive A20cko mice (A20cko-DTA+) and littermate con-
trol, transgene-negative, A20cko-DTA mice at 9–12 weeks
of age.
In A20cko-DTA+ mice, CD103+CD11b+ DCs were numerically
reduced to just 7% that of co-housed littermate A20cko-DTA
mice (Figures 7A and 7B). CD103+CD11b+ DCs in A20wt-DTA+
mice were ablated with even higher efficiency (98%). Although
previous studies reported the Langerin-DTA transgene did not
ablate other SI-LP DCs (Welty et al., 2013; Panea et al., 2015),
we found numbers of CD103CD11b+ DCs in both A20wt-DTA+
mice and A20cko-DTA+ mice were markedly reduced (Figures
7A and 7B). CD103CD11b+ DCs were on average reduced
2-fold in A20cko-DTA+ mice and as much as 8-fold in A20wt-
DTA+mice. Thus, the two DC subsets with potent IL-17-inducing
APC functions in DC/T cell co-cultures were depleted in A20cko-
DTA+ mice. These mice were not deficient in CD103+CD11b
DCs or macrophages (Figure 7B).
Compared to A20wt-DTA mice, littermate A20wt-DTA+
mice had fewer SI-LP Th17 cells (Figure 7C). This is consistent
with previous reports and supports a specialized role for
CD103+CD11b+ DCs and also CD103–CD11b+ DCs in expansion
of mucosal Th17 cells during health. In inflamed small intestine of
A20cko-DTA mice numbers of mucosal Th17 cells were mark-
edly expanded (Figure 7C). By contrast, in co-housed, littermate
A20cko-DTA+mice, Th17 expansion was significantly attenuated.
On average, Th17 cells in A20cko-DTA+ mice were just one-
third that of A20cko-DTA mice, suggesting that inflammatory
Th17 cells in A20cko mice required CD103+CD11b+ DCs and
CD103CD11b+ DCs (Figure 7C). Unlike Th17 cells, Th1 cells
were expanded >55-fold in both A20cko-DTA and DTA+ mice
Figure 6. CD103+CD11b– DCs Uniquely Up-
regulate IL-6, IL-23a, and IL-1b mRNA in a
MyD88-Independent Fashion but Do Not
Upregulate IL-17-Inducing APC Functions
(A–C) Abundance of IL-6 mRNA expressed by
SI-LP CD103+CD11b– DCs (A), CD103+CD11b+
DCs (B), or CD103–CD11b+ DCs (C), from mice of
the indicated genotype.
(D–I) Expression of IL-23(p19) (D–F), and IL-1b
mRNA (G–I) were assayed in parallel. Results are
relative to Hprt and are combined from three in-
dependent experiments, including at least 2 mice
of each genotype per experiment.
Error bars represent mean ± SEM. *p < 0.05; **p <
0.01 (unpaired Student’s t test). See also
Figure S7.
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Figure 7. In Small Intestine Inflammation,
CD103+CD11b+ DCs and CD103CD11b+
DCs Expand Inflammatory Th17 Cells
(A) Representative flow plot of SI-LP DCs in co-
housed, littermate A20cko-DTA mice and A20cko-
DTA+ mice at 9–12 weeks of age.
(B) Absolute number of each SI-LP DC subset in
A20wt or A20cko mice (either DTA or DTA+).
(C–F) Absolute number of SI-LP CD4 T cells (IL-17+
in C, IFNg+ in D, IL-17+IFNg+ in E, or Foxp3+ CD4
T cells in F) in co-housed A20wt or A20cko mice
(additionally either DTA or DTA+). Results were
combined from three independent experiments
including at least one mouse of each genotype.
Each dot represents one mouse.
Error bars represent mean ± SEM. *p < 0.05, **p <
0.01, ****p < 0.0001 (unpaired Student’s t test).(Figure 7D). Additionally, both mice had expanded numbers
of IL-17+IFNg+ and Foxp3+ T cells (Figures 7E and 7F). The
persistence of these SI-LP T cells and the marked reduction
of Th17 cells in A20cko-DTA+ mice indicates that APC functions
of CD103+CD11b+ DCs, and also CD103–CD11b+ DCs, are
required to instruct and expand inflammatory Th17 cells in the
pathogenesis of small intestine inflammation, sharing histologic
features with Crohn’s disease. Thus, in the context of pathologic
inflammation, SI-LP DCs have subset-specific APC functions
that define clear relationships between specific DCs and specific
pathologic T cells.
DISCUSSION
DCs are quintessential APCs, yet how APC functions are
controlled by microbiota is poorly understood. Our goals were
to understand the physiologic signals perceived by intestinal
DCs and the roles of these signals in DC functions and intestinal
homeostasis. We showed that APC functions of SI-LP DCs can
be potently upregulated by MyD88-independent signals and, in
a MyD88-independent fashion, microbiota, DCs, and T cells
can together drive inflammation of the small intestine that histo-
logically resembles Crohn’s disease. The pathologic potential of
MyD88-independent signals in DCs is upregulated in SI-LP DCs
lacking A20, an intracellular suppressor of MyD88-dependent
and MyD88-independent signals (Lee et al., 2000; Boone et al.,
2004; Hitotsumatsu et al., 2008; Hammer et al., 2011). Although
A20 suppression is also active in DCs outside of the intestine, it is
interesting that in non-intestinal DCs, APC functions that expand
T cells in A20cko mice require MyD88 (Hammer et al., 2011). By1340 Cell Reports 17, 1330–1343, October 25, 2016contrast, T cells in the small intestine
are expanded in a MyD88-independent
fashion, and we show microbiota drive
this expansion. Although it is possible
that microbiota stimulate DCs during the
isolation procedure, enhanced APC func-
tions of SI-LP DCs are well supported
in vivo, in which inflammation and expan-
sion of SI-LP T cells occurs in both A20cko
and A20/Myd88cko mice. Moreover, weidentified two DC subsets in A20cko mice that instruct IL-17+
T cells, and ablation of these DCs significantly diminished Th17
cells in vivo. That each SI-LP DC subset of A20cko and A20/
Myd88cko mice upregulates distinct cytokines, costimulatory
molecules, and APC functions strongly suggests that these
phenotypic and functional changes are triggered in vivo, within
the intestine microenvironment. Phenotypic and functional
changes of SI-LP macrophages do not mimic those of DCs,
and our findings and the work of others on A20-floxed Lyz2-
cremice (macrophage deletion) suggest that loss of A20-expres-
sion in macrophages is insufficient to drive inflammation in the
small intestine (Matmati et al., 2011). Collectively, our data high-
light pathologic roles for microbiota-triggered signals, indepen-
dent of MyD88, in DC expansion of microbiota-reactive T cells
and IBD pathogenesis.
IBD has two main subtypes: ulcerative colitis, which is limited
to the colon, and Crohn’s disease, which can affect any part of
the gastrointestinal tract and commonly involves the small
intestine. Small intestine inflammation also occurs in TNFDARE
mice, which overexpress TNF (Kontoyiannis et al., 1999), and
SAMP1/YitFc mice (Pizarro et al., 2011). Both develop ileitis,
although the pathologic signals are not defined. In some facil-
ities, IL-10/ mice develop inflammation of both the colon and
small intestine, and evidence suggests that different microbiota
drive pathogenesis in each intestinal organ (K€uhn et al., 1993;
Kim et al., 2005; Moran et al., 2009; Burich et al., 2001). Further
studies with A20cko and A20/Myd88cko mice, which develop
ileitis as well as inflammation of the jejunum and other regions
of the small intestine, will yield insight into how region-specific
microbiota influence disease pathogenesis.
By depleting CD103+CD11b+ and CD103CD11b+ DCs in
A20cko-DTA+ mice, we show that these DCs instruct pathologic
Th17 cells. Although previous studies with Langerin-DTA mice
reported no loss of CD103CD11b+ DCs (Welty et al., 2013;
Panea et al., 2015), this subset is heterogeneous and numbers
may differ between mouse facilities (Cerovic et al., 2013; Scott
et al., 2015). Other possibilities for these disparate findings
may be procedural differences in LP preparation or strategies
for flow cytometry gating. We found that although SI-LP DCs
equally express CD24 and CD26, the expression of CD14 and
CD64 is slightly higher on CD103CD11b+ DCs. Because these
markers discriminate DCs and macrophages, special care may
be needed to ensure proper gating of CD103CD11b+ DCs.
Understanding the functions of CD103CD11b+ DCs is of
particular interest, since our data indicate that these DCs instruct
inflammatory IL-17+ T cells, particularly downstream of MyD88
signals. We also show that CD103CD11b+ DCs, but not other
S-LP DCs, requireMyD88 for APC functions. No verifiedmethods
exist to selectively ablate CD103CD11b+ DCs, and we do not
know whether these DCs, or CD103+CD11b+ DCs, are dominant
for expansionof inflammatory Th17cells inA20ckomice.However,
CD103+CD11b+ DCs are absent in A20cko-DTA+ mice, while
50% of CD103–CD11b+ DCs remain. Thus, the Th17 cells that
persist in A20cko-DTA+ mice, which are expanded 10-fold
compared to A20wt-DTA+ mice, are likely instructed by the
remaining CD103CD11b+ DCs. These DCs must also expand
IL-17+IFNg+ T cells, since these persist in A20cko-DTA+ mice. IL-
17+IFNg+ and Th17 cells may be a spectrum of one population,
and our results with A20cko-DTA+ mice may suggest that DCs
induce RUNX or other regulators of Th17 identity (Reis et al.,
2013; Wang et al., 2014; Harbour et al., 2015). Alternatively, loss
of Th17 yet expansion of IL-17+IFNg+ T cells in A20cko-DTA+
mice may indicate that these are two separate populations, the
latter ofwhich requiresCD103CD11b+DCs.Macrophages could
further expand IL-17+ T cells (Shawet al., 2012; Panea et al., 2015;
Seo et al., 2015). However, because macrophage numbers are
normal in A20cko-DTA+ mice, our data suggest macrophages
have limited roles in expansion of inflammatory Th17 cells in dis-
ease pathogenesis of the small intestine.
Th1 cells also expanded in disease pathogenesis, and our
data suggest that CD103CD11b+ DCs and CD103+CD11b
DCs instruct IFNg+ T cells. While this paper was under review,
two studies found that CD103+CD11b DCs expand SI-LP Th1
cells during health, which supports our finding of functional
specialization of these DCs for IFNg+ T cells (Luda et al., 2016;
Ohta et al., 2016). IFNg-inducing APC functions of CD103+
CD11b DCs are also required for pathogen immunity and cyto-
protection of intestinal epithelial cells (Mashayekhi et al., 2011;
Muzaki et al., 2016). Whether these functions are shared by
CD103CD11b+ DCs is unknown.
How do DCs acquire subset-specific APC functions? What
factors reinforce APC functions that are biased? Conversely,
what factors awaken dual APC functions in CD103CD11b+
DCs?
Interaction with species of microbiota, expression of pattern
recognition receptors, signaling molecules, or signal-induced
gene transcription could be unique for each DC subset. Indeed,
we found different DCs required different signals to induce IL-6.DC expression of costimulatory molecules and cytokines and
dynamics of molecules within the immune synapse collaborate
to instruct T cell cytokines, and understanding how microbiota
control these dynamics in different DC subsets is fundamental
to understand the functional specialization of intestinal DCs.
EXPERIMENTAL PROCEDURES
Mice
A20-floxed, Myd88-floxed, Cd11c-cre, and human Langerin-DTA transgenic
mice have been described elsewhere (Kaplan et al., 2005; Caton et al.,
2007; Hou et al., 2008; Tavares et al., 2010). All mice were purchased from
the Jackson Laboratory or re-derived by embryo transfer into a maximum bar-
rier facility at Duke University. Routine screening of maximum barrier facilities
confirmed exclusion of Helicobacter, Pasteurella, and norovirus. For all breed-
ings, littermate, Cd11c-cre-negative mice were co-housed with experimental
mice and used as control, A20wt mice. Animal protocols were approved by the
Duke University Institutional Animal Care and Use Committee.
Antibiotics
Drinking water containing ampicillin (1 g/L), vancomycin (500 mg/L), neomycin
sulfate (1 g/L), and metronidazole (1 g/L) was provided on day 18–19 of gesta-
tion or to dams within 2 days after delivery. Weaned pups received antibiotics
for an additional 6–7 weeks. Stool DNAwas prepared using PowerSoil (Mo bio)
and 16S DNA quantified using the following primers: 50-ACTCCTACGGGA
GGCAGCAGT-30, 50-GTATTACCGCGGCTGCTGGCAC-30 (Bergstro¨m et al.,
2012).
Intestinal Lamina Propria Preparation
Small intestine was flushed with HBSS/10 mM HEPES and Peyer’s patches
removed. Intestine was cut longitudinally and washed thoroughly with
HBSS/10 mM HEPES to remove lumen contents. Organ weight was recorded
after brief wicking of liquid. Intestine was then cut into 0.5-cm pieces and
processed according to methods specified by the lamina propria dissociation
kit and GentleMACS Dissociator (Miltenyi Biotec), with modifications as
described in Supplemental Experimental Procedures.
Flow Cytometry, Cell Sorting, and DC/T Cell Co-cultures
SI-LP cells were stained with Live/Dead fixable dead cell staining (Thermo
Fisher Scientific) and immune populations gated as follows: CD4 T cells
(CD45+TCRb+CD4+), DCs (CD45+IA/IE+CD11c+CD24+CD14), and macro-
phages (CD45+IA/IE+CD11b+CD24CD14+CD103). For cytokine stains, SI-
LP cells were stimulated for 4 hr with PMA (50 ng/mL) and ionomycin
(500 ng/mL) in the presence of brefeldin A. Cells were analyzed on a BD Canto
or sorted with Astrios (Beckman Coulter).
Sorted SI-LPmacrophages were gated as IA/IEhiCD14+CD11b+CD103. To
sort SI-LP DCs, cells were first enriched by CD11c microbeads and an
AutoMACS (Miltenyi), or by Nycoprep centrifugation (Axis-Shield). DCs were
gated as IA/IEhiCD11c+CD26+CD14 and then subsetted by CD103 and
CD11b expression. For co-cultures, negatively enriched (EasySep) OT-II
T cells were sorted for TCRb+CD4+CD62LhiCD44lowCD25. These naive OT-
II T cells were co-cultured for 4 days with DCs or macrophages at a 1:1 ratio
in a 96-well round-bottom plate. Co-cultures also included endotoxin-free
OVA peptide (5 mg/mL, JPT) and TGF-b (1 ng/mL, PeproTech). Within a given
experiment, each well contained an equivalent number of DCs (of an individual
DC subset) or macrophages from mice of each genotype. Some experiments
included 10 mg/mL of the following antibodies: rat immunoglobulin G (IgG)
(RTK2071), hamster IgG (G235-2356), anti-CD80 (16-10A1), anti-CD86 (GL1)
or anti-IL-6 (MP5-20F3). IL-17A, IFNg, and IL-6 in supernatants were assayed
by ELISA (BioLegend). Cytokine+ T cells were assayed by 4-hr re-stimulation
with plate-bound anti-CD3 (5 mg/mL) and anti-CD28 (5 mg/mL). Results from
ELISA and T cell numbers were normalized to 1,000 input naive OT-II cells.
qPCR
For details regarding qPCR, please see the Supplemental Experimental
Procedures.Cell Reports 17, 1330–1343, October 25, 2016 1341
Histology
Five 2-cm segments of the small intestine were collected in accordance with
defined anatomic locations (Treuting andDintzis, 2012). The first segment con-
tained a small portion of the lower stomach and the pylorus-adjacent intestine,
which includes the duodenum and proximal jejunum. This was followed imme-
diately after by two contiguous segments of the proximal jejunum. The fourth
segment contained themiddle small intestine (jejunum-ileum), and the last was
adjacent to the ileocecal junction (terminal ileum). Segments were color-coded
and fixed in Carnoy’s, and sections were stained with H&E. Slides were coded
to blind the pathologist and each segment scored using a previously described
scoring system (Hale et al., 2005), with modifications as described in the
Supplemental Experimental Procedures.
Statistical Analysis
Student’s t test (GraphPad Prism) was used for statistical analysis.
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